R.L. Batista, B.B. Mendonca, The molecular basis of 5α-reductase type 2 deficiency. Sex. Dev. 16, 171–183 (2022). https://doi.org/10.1159/000525119.

Article  CAS  PubMed  Google Scholar 

L. Audí, S.F. Ahmed, N. Krone, M. Cools, K. McElreavey, P.M. Holterhus, A. Greenfield, A. Bashamboo, O. Hiort, S.A. Wudy, R. McGowan, Genetics in endocrinology: approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST action BM 1303 ‘DSDnet’. Eur. J. Endocrinol. 179, R197–R206 (2018). https://doi.org/10.1530/EJE-18-0256.

Article  PubMed  PubMed Central  Google Scholar 

N. Akcan, O. Uyguner, F. Baş, U. Altunoğlu, G. Toksoy, B. Karaman, Ş Avcı, Z. Yavaş Abalı, Ş Poyrazoğlu, A. Aghayev, V. Karaman, R. Bundak, S. Başaran, F. Darendeliler, Mutations in AR or SRD5A2 genes: clinical findings, endocrine pitfalls, and genetic features of children with 46,XY DSD. J. Clin. Res. Pediatr. Endocrinol. 14, 153–171 (2022). https://doi.org/10.4274/jcrpe.galenos.2022.2021-9-19.

Article  PubMed  PubMed Central  Google Scholar 

M. Fernández-Cancio, L. Audí, P. Andaluz, N. Torán, C. Piró, M. Albisu, M. Gussinyé, D. Yeste, M. Clemente, J. Martínez-Mora, A. Blanco, M.L. Granada, M. Marco, J. Ferragut, J.P. López-Siguero, M. Beneyto, C. Carles, A. Carrascosa, SRD5A2 gene mutations and polymorphisms in Spanish 46,XY patients with a disorder of sex differentiation. Int. J. Androl. 34, e526–e535 (2011). https://doi.org/10.1111/j.1365-2605.2010.01136.x.

Article  CAS  PubMed  Google Scholar 

A. Nicoletti, L. Baldazzi, A. Balsamo, L. Barp, P. Pirazzoli, M. Gennari, G. Radetti, E. Cacciari, A. Cicognani, SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. Clin. Endocrinol. 63, 375–380 (2005). https://doi.org/10.1111/j.1365-2265.2005.02348.x.

Article  CAS  Google Scholar 

A. Avendaño, I. Paradisi, F. Cammarata-Scalisi, M. Callea, 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? a review. Hormones 17, 197–204 (2018). https://doi.org/10.1007/s42000-018-0013-9.

Article  PubMed  Google Scholar 

P.T. Cohen-Kettenis, Gender change in 46,XY persons with 5α-reductase-2 deficiency and 17β-hydroxysteroid dehydrogenase-3 deficiency. Arch. Sex. Behav. 34, 399–410 (2005). https://doi.org/10.1007/s10508-005-4339-4.

Article  PubMed  Google Scholar 

A. Konishi, S. Ida, F. Matsui, Y. Etani, M. Kawai, Male assignment in 5α-reductase type 2 deficiency with female external genitalia. Pediatr Int. 63, 592–594 (2021). https://doi.org/10.1111/ped.14447.

Article  CAS  PubMed  Google Scholar 

T.C. van de Grift, M. Rapp, G. Holmdahl, L. Duranteau, A. Nordenskjold, B. Kohler, U. Neumann, P. Cohen-Kettenis, B. Kreukels, A. de Vries, W. Arlt, C. Wiesemann, J. Slowikowska-Hilczer, U. Thyen, M. Rapp, A.B. de la Perriere, C. Sultan, F. Paris, N. Reisch, A. Richter-Unruh, H. Claahsen–van der Grinten, C. Bouvattier, L. Duranteau, A. Nordenström, A. Nordenskjöld, C. Pienkowski, M. Szarras-Czapnik, Masculinizing surgery in disorders/differences of sex development: clinician- and participant-evaluated appearance and function. BJU Int. 129, 394–405 (2022). https://doi.org/10.1111/bju.15369.

Article  PubMed  Google Scholar 

S.H. Williamson, C.A. Davis-Dao, K.H. Huen, L. Ehwerhemuepha, K. Chuang, H.A. Stephany, E.J. Wehbi, Z.N. Kain, Timely orchiopexy by 18 months of age: are we meeting the standards defined by the 2014 AUA guidelines?. J. Pediatr. Urol. 18, 683.e1–683.e7 (2022). https://doi.org/10.1016/j.jpurol.2022.07.008.

Article  PubMed  Google Scholar 

S. van der Straaten, A. Springer, A. Zecic, D. Hebenstreit, U. Tonnhofer, A. Gawlik, M. Baumert, K. Szeliga, S. Debulpaep, A. Desloovere, L. Tack, K. Smets, M. Wasniewska, D. Corica, M. Calafiore, M.L. Ljubicic, A.S. Busch, A. Juul, A. Nordenström, J. Sigurdsson, C.E. Flück, T. Haamberg, S. Graf, S.E. Hannema, K.P. Wolffenbuttel, O. Hiort, S.F. Ahmed, M. Cools, The external genitalia score (EGS): a European multicenter validation study. J. Clin. Endocrinol. Metab. 105, e222–e230 (2020). https://doi.org/10.1210/clinem/dgz142.

Article  Google Scholar 

C.A. Quigley, A. De Bellis, K.B. Marschke, M.K. el-Awady, E.M. Wilson, F.S. French, Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 16, 271–321 (1995). https://doi.org/10.1210/edrv-16-3-271.

Article  CAS  PubMed  Google Scholar 

M.E. Kars, A.N. Başak, O.E. Onat, K. Bilguvar, J. Choi, Y. Itan, C. Çağlar, R. Palvadeau, J.-L. Casanova, D.N. Cooper, P.D. Stenson, A. Yavuz, H. Buluş, M. Günel, J.M. Friedman, T. Özçelik, The genetic structure of the Turkish population reveals high levels of variation and admixture. Proc. Natl Acad. Sci. 118, e2026076118 (2021). https://doi.org/10.1073/pnas.2026076118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W.W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H.L. Rehm, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 17, 405–424 (2015). https://doi.org/10.1038/gim.2015.30.

Article  PubMed  PubMed Central  Google Scholar 

N.E. Allen, M.S. Forrest, T.J. Key, The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol. Biomark. Prev. 10, 185–189 (2001).

CAS  Google Scholar 

E. Bonnet, M. Winter, D. Mallet, I. Plotton, C. Bouvattier, M. Cartigny, L. Martinerie, M. Polak, A. Bachelot, F. Huet, S. Baron, M. Houang, S. Soskin, A. Lienhardt, J. Bertherat, C. Amouroux, A. Bouty, L. Duranteau, R. Besson, A. El Ghoneimi, D. Samara-Boustani, F. Becmeur, N. Kalfa, F. Paris, F. Medjkane, A. Brac de la Perrière, P. Bretones, H. Lejeune, M. Nicolino, P. Mouriquand, D.-B. Gorduza, C.-L. Gay, Changes in the clinical management of 5α-reductase type 2 and 17β-hydroxysteroid dehydrogenase type 3 deficiencies in France. Endocr. Connect. 12, e220227 (2023). https://doi.org/10.1530/EC-22-0227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

R.L. Batista, B.B. Mendonca, Integrative and analytical review of the 5-alpha-reductase type 2 deficiency worldwide. Appl. Clin. Genet. 13, 83–96 (2020). https://doi.org/10.2147/TACG.S198178.

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Maimoun, P. Philibert, B. Cammas, F. Audran, P. Bouchard, P. Fenichel, M. Cartigny, C. Pienkowski, M. Polak, N. Skordis, I. Mazen, G. Ocal, M. Berberoglu, R. Reynaud, C. Baumann, S. Cabrol, D. Simon, K. Kayemba-Kay’s, M. De Kerdanet, F. Kurtz, B. Leheup, C. Heinrichs, S. Tenoutasse, G. Van Vliet, A. Grüters, M. Eunice, A.C. Ammini, M. Hafez, Z. Hochberg, S. Einaudi, H. Al Mawlawi, C.J. del Valle Nuñez, N. Servant, S. Lumbroso, F. Paris, C. Sultan, Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J. Clin. Endocrinol. Metab. 96, 296–307 (2011). https://doi.org/10.1210/jc.2010-1024.

Article  CAS  PubMed  Google Scholar 

T. Akcay, M. Fernandez-Cancio, S. Turan, T. Güran, L. Audi, A. Bereket, AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. Andrology 2, 572–578 (2014). https://doi.org/10.1111/j.2047-2927.2014.00215.x.

Article  CAS  PubMed  Google Scholar 

I. Turan, M. Tastan, D.D. Boga, F. Gurbuz, L.D. Kotan, A. Tuli, B. Yüksel, 21-hydroxylase deficiency: mutational spectrum and genotype–phenotype relations analyses by next-generation sequencing and multiplex ligation-dependent probe amplification. Eur. J. Med. Genet. 63, 103782 (2020). https://doi.org/10.1016/j.ejmg.2019.103782.

Article  PubMed  Google Scholar 

A.O.K. Chan, B.W.M. But, C.Y. Lee, Y.Y. Lam, K.L. Ng, J.Y.L. Tung, E.Y.W. Kwan, Y.K. Chan, T.K.C. Tsui, A.L.N. Lam, W.Y. Tse, P.T. Cheung, C.C. Shek, Diagnosis of 5α-reductase 2 deficiency: is measurement of dihydrotestosterone essential?. Clin. Chem. 59, 798–806 (2013). https://doi.org/10.1373/clinchem.2012.196501.

Article  CAS  PubMed  Google Scholar 

N.S. Marzuki, F.P. Idris, H.D. Kartapradja, A.R. Harahap, J.R.L. Batubara, Characterising SRD5A2 gene variants in 37 Indonesian patients with 5-alpha-reductase type 2 deficiency. Int. J. Endocrinol. 2019, 1–10 (2019). https://doi.org/10.1155/2019/7676341.

Article  CAS  Google Scholar 

L. Fan, Y. Song, M. Polak, L. Li, X. Ren, B. Zhang, D. Wu, C. Gong, Clinical characteristics and genotype-phenotype correlations of 130 Chinese children in a high-homogeneity single-center cohort with 5α-reductase 2 deficiency. Mol. Genet. Genom. Med. 8, e1431 (2020). https://doi.org/10.1002/mgg3.1431.

Article  CAS  Google Scholar 

J. Cheng, R. Lin, W. Zhang, G. Liu, H. Sheng, X. Li, Z. Zhou, X. Mao, L. Liu, Phenotype and molecular characteristics in 45 Chinese children with 5α-reductase type 2 deficiency from South China. Clin. Endocrinol. 83, 518–526 (2015). https://doi.org/10.1111/cen.12799.

Article  CAS  Google Scholar 

A. Abacı, G. Çatlı, Ö Kırbıyık, N.M. Şahin, Z.Y. Abalı, E. Ünal, Z. Şıklar, E. Mengen, S. Özen, T. Güran, C. Kara, M. Yıldız, E. Eren, Ö Nalbantoğlu, A. Güven, A. Çayır, E.D. Akbaş, Y. Kor, Y. Çürek, Z. Aycan, F. Baş, Ş Darcan, M. Berberoğlu, Genotype–phenotype correlation, gonadal malignancy risk, gender preference, and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency: a multicenter study from Turkey. J. Endocrinol. Invest. 42, 453–470 (2019). https://doi.org/10.1007/s40618-018-0940-y.

Article  CAS  PubMed  Google Scholar 

S. Bertelloni, F. Baldinotti, G. Russo, P. Ghirri, E. Dati, A. Michelucci, F. Moscuzza, S. Meroni, I. Colombo, M.R. Sessa, G.I. Baroncelli, 5α-reductase-2 deficiency: clinical findings, endocrine pitfalls, and genetic features in a large Italian cohor